Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations
{{output}}
The global burden of breast cancer highlights the need for primary prevention strategies that demonstrate both favorable clinical benefit/risk profile and good value for money. Endocrine therapy with selective estrogen-receptor modulators (SERMs) or aromatase ... ...
